2
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Breast
1
Conditions
Pancreatic Neoplasms
9
Peutz-Jeghers Syndrome
3
Exocrine Pancreatic Insufficiency
2
Pancreatic Intraductal Neoplasms
1
Intraductal Papillary Mucinous Neoplasms
1
Hereditary pancreatitis
1
Hereditary Sensory and Autonomic Neuropathies
1
Fanconi Anemia, Complementation Group D1
1
Dysplastic Nevus Syndrome
1
Diabetes Mellitus
1
Colorectal Neoplasms, Hereditary Nonpolyposis
1
Breast Neoplasms
1
Interventions
Dermoscopy
2
pembrolizumab
1
Transdermal Patch
1
Sutures
1
Standard of Care
1
Secretin
1
Practice Guidelines as Topic
1
Pharmaceutical Preparations
1
Nivolumab
1
Magnetic Resonance Spectroscopy
1
Genome
1
Endoscopic Ultrasound-Guided Fine Needle Aspiration
1
Diagnostic Imaging
1
Data Collection
1
CA-19-9 Antigen
1
Betulinic Acid
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Dysplastic Nevus Syndrome
×
Secretin
×
Clear all
NCT02000089
2025-10-09
CAPS5
Johns Hopkins University
Phase 3
Recruiting
9,000 enrolled